Does propofol or caffeic acid phenethyl ester prevent lung injury after hindlimb ischaemia-reperfusion in ventilated rats?
Introduction
Lower limb ischaemia followed by reperfusion is an important and common clinical event. Reperfusion initiates both local and systemic damage, in part through rapid oxygen free radical generation and inflammatory mediators.16 Restoration of the blood flow can save the limb, but may result in multiple organ dysfunction syndrome. One of these target organs after hindlimb ischaemia-reperfusion (IR) injury is the lung, and clinically, the pulmonary damage in this condition may cause from acute lung injury with mild dysfunction to severe respiratory failure or adult respiratory distress syndrome. The main pathological defect in lung injury after reperfusion is the endothelial cell damage caused by activated neutrophils and the formation of free radicals.11 Pulmonary vasoconstriction, hypertension, and increased pulmonary vascular permeability are common results of impaired endothelial cell function.3 Therefore, inhibiting neutrophil activation or blocking reactive oxygen species could be the key to preventing clinical outcomes of the lung tissue damage caused by hindlimb IR injury.9
Many chemicals have been tested to attenuate IR injury. One of these, caffeic acid phenethyl ester (CAPE), a flavonoid like compound, is one of the major components of honeybee propolis. CAPE, with no harmful effects on normal cells, has several biological and pharmacological properties: antioxidant, anti-inflammatory, anti-carcinogenic, antiviral, and immunomodulatory activities. In many studies, it is clearly showed that CAPE, at a concentration of 10 μmol, completely blocks production of reactive oxygen species in human neutrophils.9
Propofol (2,6-diisopropylphenol) is a widely used intravenous anaesthetic, and is chemically similar to phenol-based free radical scavengers. Importantly, it is also a potent antioxidant, and has anti-inflammatory properties. Propofol may be expected to have beneficial effects in the management of patients with acute lung injury and adult respiratory distress syndrome.8 Propofol can increase the antioxidant capacity of the tissues by the inhibition of lipid peroxidation in cell membranes following reperfusion injury.17 Additionally, it attenuates IR induced lipid peroxidation when given in therapeutic doses for the induction and maintenance of general anaesthesia.10
We performed this study to examine the effectiveness of propofol and CAPE pretreatment in preventing lung injury caused by lower limb IR during mechanical ventilation with positive end-expiratory pressure in a rat model. For this purpose, we assessed biochemical parameters and histopathological analysis of the lungs.
Section snippets
Animals and groups
Thirty-two adult male Sprague Dawley rats, weighing 270–320 g, were used. All animal procedures were in strict accordance with the National Institutes of Health Guidelines on the Care and Use of Laboratory Animals. The approval of the Karadeniz Technical University, Faculty of Medicine, Animal Care and Ethics Committee was obtained before the study began.
Animals were allocated randomly into one of 4 groups: I; sham group, no IR, (n = 8), II; control group; IR, (n = 8), III; CAPE group; IR with CAPE,
Results
There were no significant differences between the groups in terms of body weight, time between induction of anaesthesia and start of procedure.
Discussion
The role of neutrophils and oxidative damage in the lung following lower IR injury is well-established. Almost 25 years ago, it was reported that limb IR injury may not only lead to increased vascular permeability in the skeletal muscle but also in the lung.7 In this study, we also showed that the lung, as a remote organ, is affected by IR of the lower extremities. Supporting this, MDA levels in plasma and lung tissue were found to be higher in the control group. In addition, higher MPO
Conclusion
On the basis of our experimental results, we have shown that CAPE or propofol cause a significant inhibition of MDA production and neutrophil infiltration in the lungs, and that, histopathologically, these may have a protective effect in hindlimb IR-induced lung injury. At this point, and more importantly, we determined that propofol is as effective in preventing the injury as CAPE. Therefore, these results indicate that there may be a benefit from using propofol as an anaesthetic agent in
Acknowledgments
We would like to thank Asst. Prof. Dr. Murat Topbaş MD for providing statistical analysis and Yıldıray Yığcı for providing expert technical assistance.
References (22)
- et al.
The widely used anesthetic agent propofol can replace α-tocopherol as an antioxidant
FEBS Lett
(1995) - et al.
Ischaemia and reperfusion injury: prevention of pulmonary hypertension and leukosequestrasy on following lower limb ischaemia
Prostagland Leukotrienes Essent Fatty Acids
(1997) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
Anal Biochem
(1976)- et al.
The effect of caffeic acid phenetyl ester on tissue damage in lung after hindlimb ischaemia-reperfusion
Pharmacol Res
(2003) - et al.
Spesificity and properties of propofol as an antioxidant free radical scavenger
Toxicol Appl Pharmacol
(1994) - et al.
Inhibition of poly(ADP-ribose) polymerase attenuates lung tissue damage after hindlimb ischaemia-repefusion in rats
Pharmacol Res
(2005) - et al.
The role of glutamine in skeletal muscle ischaemia/reperfusion injury in the rat hind limb model
Am J Surg
(1999) - et al.
Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery
Br J Anaesth
(2002) - et al.
Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase
J Pharmacol Methods
(1990) - et al.
FK506 to prevent lung injury after hindlimb ischaemia and reperfusion in a rat model: an electron microscopic study
Surg Today
(2004)